| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 152, 943-951, Copyright © 1998 by American Society for Investigative Pathology
REGULAR ARTICLES |
EM Gravallese, Y Harada, JT Wang, AH Gorn, TS Thornhill and SR Goldring
Department of Cancer Biology, Harvard School of Public Health, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Focal resorption of bone at the bone-pannus interface is common in rheumatoid arthritis (RA) and juvenile rheumatoid arthritis (JRA) and can result in significant morbidity. However, the specific cellular and hormonal mechanisms involved in this process are not well established. We examined tissue sections from areas of bone erosion in patients with RA and JRA. Multinucleated cells (MNCs) were present in resorption lacunae in areas of calcified cartilage and in subchondral bone immediately adjacent to calcified cartilage, as previously described. mRNA for the calcitonin receptor (CTR) was localized to these MNCs in bone resorption lacunae, a finding that definitively identifies these cells as osteoclasts. These MNCs were also positive for tartrate- resistant acid phosphatase (TRAP) mRNA and TRAP enzymatic activity. Occasional mononuclear cells on the bone surface were also CTR positive. Mononuclear cells and MNCs not on bone surfaces were CTR negative. The restriction of CTR-positive cells to the surface of mineralized tissues suggests that bone and/or calcified cartilage provide signals that are critical for the differentiation of hematopoietic osteoclast precursors to fully differentiated osteoclasts. Some MNCs and mononuclear cells off bone and within invading tissues were TRAP positive. These cells likely represent the precursors of the CTR-TRAP-positive cells on bone. Parathyroid hormone receptor mRNA was present in cells with the phenotypic appearance of osteoblasts, in close proximity to MNCs, and in occasional cells within pannus tissue, but not in the MNCs in bone resorption lacunae. These findings demonstrate that osteoclasts within the rheumatoid lesion do not express parathyroid hormone receptor. In conclusion, the resorbing cells in RA exhibit a definitive osteoclastic phenotype, suggesting that pharmacological agents that inhibit osteoclast recruitment or activity are rational targets for blocking focal bone erosion in patients with RA and JRA.
This article has been cited by other articles:
 |
|
 |
|
  G Schett, J Zwerina, and G Firestein The p38 mitogen-activated protein kinase (MAPK) pathway in rheumatoid arthritis Ann Rheum Dis, July 1, 2008; 67(7): 909 - 916. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Schett Joint remodelling in inflammatory disease Ann Rheum Dis, November 1, 2007; 66(suppl_3): iii42 - iii44. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Schett, R. Landewe, and D. van der Heijde Tumour necrosis factor blockers and structural remodelling in ankylosing spondylitis: what is reality and what is fiction? Ann Rheum Dis, June 1, 2007; 66(6): 709 - 711. [Full Text] [PDF]
|
|
|
|
 |
|
 K. Nakano, Y. Okada, K. Saito, R. Tanikawa, N. Sawamukai, Y. Sasaguri, T. Kohro, Y. Wada, T. Kodama, and Y. Tanaka Rheumatoid synovial endothelial cells produce macrophage colony-stimulating factor leading to osteoclastogenesis in rheumatoid arthritis Rheumatology, April 1, 2007; 46(4): 597 - 603. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Mancini, M. J. Paul-Clark, G. Rosignoli, R. Hannon, J. E. Martin, I. Macintyre, and M. Perretti Calcitonin and Prednisolone Display Antagonistic Actions on Bone and Have Synergistic Effects in Experimental Arthritis Am. J. Pathol., March 1, 2007; 170(3): 1018 - 1027. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. R. Pettit, N. C. Walsh, C. Manning, S. R. Goldring, and E. M. Gravallese RANKL protein is expressed at the pannus-bone interface at sites of articular bone erosion in rheumatoid arthritis Rheumatology, September 1, 2006; 45(9): 1068 - 1076. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U.H. Lerner Inflammation-induced Bone Remodeling in Periodontal Disease and the Influence of Post-menopausal Osteoporosis. J. Dent. Res., July 1, 2006; 85(7): 596 - 607. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Nakamura, T. Kukita, T. Shobuike, K. Nagata, Z. Wu, K. Ogawa, T. Hotokebuchi, O. Kohashi, and A. Kukita Inhibition of Histone Deacetylase Suppresses Osteoclastogenesis and Bone Destruction by Inducing IFN-{beta} Production J. Immunol., November 1, 2005; 175(9): 5809 - 5816. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Jimenez-Boj, K. Redlich, B. Turk, B. Hanslik-Schnabel, A. Wanivenhaus, A. Chott, J. S. Smolen, and G. Schett Interaction between Synovial Inflammatory Tissue and Bone Marrow in Rheumatoid Arthritis J. Immunol., August 15, 2005; 175(4): 2579 - 2588. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Hayer, G. Steiner, B. Gortz, E. Reiter, M. Tohidast-Akrad, M. Amling, O. Hoffmann, K. Redlich, J. Zwerina, K. Skriner, et al. CD44 is a determinant of inflammatory bone loss J. Exp. Med., March 21, 2005; 201(6): 903 - 914. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Kishimoto, S. Fukumoto, S. Nishihara, H. Mizumura, K. Hirai, and R. Teshima Gene expression relevant to osteoclastogenesis in the synovium and bone marrow of mature rats with collagen-induced arthritis Rheumatology, December 1, 2004; 43(12): 1496 - 1503. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S-M Dai, K Nishioka, and K Yudoh Interleukin (IL) 18 stimulates osteoclast formation through synovial T cells in rheumatoid arthritis: comparison with IL1{beta} and tumour necrosis factor {alpha} Ann Rheum Dis, November 1, 2004; 63(11): 1379 - 1386. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D O' Gradaigh, D Ireland, S Bord, and J E Compston Joint erosion in rheumatoid arthritis: interactions between tumour necrosis factor {alpha}, interleukin 1, and receptor activator of nuclear factor {kappa}B ligand (RANKL) regulate osteoclasts Ann Rheum Dis, April 1, 2004; 63(4): 354 - 359. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J S Smolen and D Aletaha Patients with rheumatoid arthritis in clinical care Ann Rheum Dis, March 1, 2004; 63(3): 221 - 225. [Full Text] [PDF]
|
|
|
|
|
|
K. Redlich, B. Gortz, S. Hayer, J. Zwerina, N. Doerr, P. Kostenuik, H. Bergmeister, G. Kollias, G. Steiner, J. S. Smolen, et al. Repair of Local Bone Erosions and Reversal of Systemic Bone Loss Upon Therapy with Anti-Tumor Necrosis Factor in Combination with Osteoprotegerin or Parathyroid Hormone in Tumor Necrosis Factor-Mediated Arthritis Am. J. Pathol., February 1, 2004; 164(2): 543 - 555. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. O'Gradaigh and J. E. Compston T-cell involvement in osteoclast biology: implications for rheumatoid bone erosion Rheumatology, February 1, 2004; 43(2): 122 - 130. [Full Text] [PDF]
|
|
|
|
 |
|
 W. Zou, A. Amcheslavsky, and Z. Bar-Shavit CpG Oligodeoxynucleotides Modulate the Osteoclastogenic Activity of Osteoblasts via Toll-like Receptor 9 J. Biol. Chem., May 2, 2003; 278(19): 16732 - 16740. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H Tsuboi, Y Matsui, K Hayashida, S Yamane, M Maeda-Tanimura, A Nampei, J Hashimoto, R Suzuki, H Yoshikawa, and T Ochi Tartrate resistant acid phosphatase (TRAP) positive cells in rheumatoid synovium may induce the destruction of articular cartilage Ann Rheum Dis, March 1, 2003; 62(3): 196 - 203. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E M Gravallese, A R Pettit, R Lee, R Madore, C Manning, A Tsay, J Gaspar, M B Goldring, S R Goldring, and P Oettgen Angiopoietin-1 is expressed in the synovium of patients with rheumatoid arthritis and is induced by tumour necrosis factor {alpha} Ann Rheum Dis, February 1, 2003; 62(2): 100 - 107. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E M Gravallese Bone destruction in arthritis Ann Rheum Dis, November 1, 2002; 61(90002): ii84 - 86. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Romas, N. A. Sims, D. K. Hards, M. Lindsay, J. W.M. Quinn, P. F.J. Ryan, C. R. Dunstan, T. J. Martin, and M. T. Gillespie Osteoprotegerin Reduces Osteoclast Numbers and Prevents Bone Erosion in Collagen-Induced Arthritis Am. J. Pathol., October 1, 2002; 161(4): 1419 - 1427. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. B. Abramson and A. Amin Blocking the effects of IL-1 in rheumatoid arthritis protects bone and cartilage Rheumatology, September 1, 2002; 41(9): 972 - 980. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. A. Ragab, J. L. Nalepka, Y. Bi, and E. M. Greenfield Cytokines synergistically induce osteoclast differentiation: support by immortalized or normal calvarial cells Am J Physiol Cell Physiol, September 1, 2002; 283(3): C679 - C687. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. K. de Hooge, F. A. J. van de Loo, M. B. Bennink, D. S. de Jong, O. J. Arntz, E. Lubberts, C. D. Richards, and W. B. van den Berg Adenoviral Transfer of Murine Oncostatin M Elicits Periosteal Bone Apposition in Knee Joints of Mice, Despite Synovial Inflammation and Up-Regulated Expression of Interleukin-6 and Receptor Activator of Nuclear Factor-{kappa}B Ligand Am. J. Pathol., May 1, 2002; 160(5): 1733 - 1743. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M Corr and N J Zvaifler Mesenchymal precursor cells Ann Rheum Dis, January 1, 2002; 61(1): 3 - 5. [Full Text] [PDF]
|
|
|
|
|
|
A. R. Pettit, H. Ji, D. von Stechow, R. Muller, S. R. Goldring, Y. Choi, C. Benoist, and E. M. Gravallese TRANCE/RANKL Knockout Mice Are Protected from Bone Erosion in a Serum Transfer Model of Arthritis Am. J. Pathol., November 1, 2001; 159(5): 1689 - 1699. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. R. Haynes, T. N. Crotti, M. Loric, G. I. Bain, G. J. Atkins, and D. M. Findlay Osteoprotegerin and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclast formation by cells in the human rheumatoid arthritic joint Rheumatology, June 1, 2001; 40(6): 623 - 630. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. T. Engsig, Q.-J. Chen, T. H. Vu, A.-C. Pedersen, B. Therkidsen, L. R. Lund, K. Henriksen, T. Lenhard, N. T. Foged, Z. Werb, et al. Matrix Metalloproteinase 9 and Vascular Endothelial Growth Factor Are Essential for Osteoclast Recruitment into Developing Long Bones J. Cell Biol., November 13, 2000; 151(4): 879 - 890. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. R Goldring The final pathogenetic steps in focal bone erosions in rheumatoid arthritis Ann Rheum Dis, November 1, 2000; 59(90001): i72 - 74. [Full Text] [PDF]
|
|
|
|
|
|
T. Kaneda, T. Nojima, M. Nakagawa, A. Ogasawara, H. Kaneko, T. Sato, H. Mano, M. Kumegawa, and Y. Hakeda Endogenous Production of TGF-{beta} Is Essential for Osteoclastogenesis Induced by a Combination of Receptor Activator of NF-{kappa}B Ligand and Macrophage-Colony- Stimulating Factor J. Immunol., October 15, 2000; 165(8): 4254 - 4263. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Bresnihan, P. P. Tak, P. Emery, L. Klareskog, and F. Breedveld Synovial biopsy in arthritis research: five years of concerted European collaboration Ann Rheum Dis, July 1, 2000; 59(7): 506 - 511. [Full Text]
|
|
|
|
|
|
T. Kawai, R. Eisen-Lev, M. Seki, J. W. Eastcott, M. E. Wilson, and M. A. Taubman Requirement of B7 Costimulation for Th1-Mediated Inflammatory Bone Resorption in Experimental Periodontal Disease J. Immunol., February 15, 2000; 164(4): 2102 - 2109. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. R. Goldring A 55-Year-Old Woman With Rheumatoid Arthritis JAMA, January 26, 2000; 283(4): 524 - 531. [Full Text] [PDF]
|
|
|
|
 |
|
 Y. R. Nakasato, A. J. Janckila, J. M. Halleen, H. K. Vaananen, S. P. Walton, and L. T. Yam Clinical Significance of Immunoassays for Type-5 Tartrate-resistant Acid Phosphatase Clin. Chem., December 1, 1999; 45(12): 2150 - 2157. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
